Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. - Wikidata - wikimedia - TriplyDB

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.

http://www.wikidata.org/entity/Q42655084

about

Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13)Citalopram versus other anti-depressive agents for depression Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains Proteoglycans and neuronal migration in the cerebral cortex during development and disease Exploring the effects of polymorphisms on cis-regulatory signal transduction response Cognitive mechanisms of treatment in depression Pharmacogenomics discovery and implementation in genome-wide association studies era From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis A genome-wide association study of antidepressant response in Koreans Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial Progress and prospects in pharmacogenetics of antidepressant drugs.Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response Highly polygenic architecture of antidepressant treatment response: Comparative analysis of SSRI and NRI treatment in an animal model of depression Antidepressant treatment response is modulated by genetic and environmental factors and their interactions.Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.Pharmacogenetics of antidepressant response.Biomarkers to predict antidepressant response Convergent evidence from mouse and human studies suggests the involvement of zinc finger protein 326 gene in antidepressant treatment response.Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis A genome-wide association study of a sustained pattern of antidepressant response Understanding the pharmacogenetics of selective serotonin reuptake inhibitors.Epigenetic alterations in depression and antidepressant treatment Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levels.Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders.Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics.Cytokine variations and mood disorders: influence of social stressors and social support.Leptin receptor deficiency confers resistance to behavioral effects of fluoxetine and desipramine via separable substrates.Copy number variants in pharmacogenetic genes.Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study.Pharmacogenetics of antidepressants Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology.Genome-wide association studies of antidepressant outcome: a brief review.Putative transcriptomic biomarkers in the inflammatory cytokine pathway differentiate major depressive disorder patients from control subjects and bipolar disorder patients.Investigation of blood mRNA biomarkers for suicidality in an independent sample High dimensional endophenotype ranking in the search for major depression risk genes.Genetic variants in combination with early partial improvement as a clinical utility predictor of treatment outcome in major depressive disorder: the result of two pooled RCTs.The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.PharmGKB summary: citalopram pharmacokinetics pathway.

P2860

Q21134099-383A0F56-5261-477E-8BC2-5F61458A7EDE Q24202141-C943DBCF-4E1C-4277-BECD-9084D65E6747 Q24632901-35BAE52E-7935-41F1-B207-BC1973FC433A Q26825110-819AA9D8-01DF-467E-AB2C-68AF952F772C Q26991710-CBCD73E6-F735-4D5A-849C-336906CA7601 Q27001088-1833C96C-86FB-44EC-998E-2AF6EF962D2B Q27001573-447800F6-28A3-4225-B124-277E80F026F3 Q27015830-C2746F9A-47D9-4B9E-AC82-1CF2C9734604 Q28484419-6FBD2DB2-4F35-4893-8E5A-1B255CF8A8E7 Q28597255-7FA1C10F-8268-4954-B255-293B3B260B07 Q28710054-EA166BBC-1334-461A-8753-21E1439B13BA Q30249569-DC86DC0E-AE0D-4CAC-A4B1-2753A0EC288A Q31130220-A7A1D0E4-5529-44FE-AAB6-ED0313C2D42B Q33697992-90991FFC-DC9C-40E0-9D1F-95245B5AD20D Q33930731-A2027FD0-C672-4FB6-BC4F-D4B9B382498D Q34131354-7C4E3C57-0957-4ABA-ADCE-0978197836B3 Q34155796-E6113C0B-B75E-485B-B7CF-612F060B605F Q34247513-EC5D4239-5F9A-4147-BAFF-26F82DBF8C0C Q34292369-678CBEE8-81CC-43A4-B44E-56A2A1A03896 Q34343309-B3878E4A-069D-493E-8C39-1CAF305B53FC Q34347951-5245B084-C63D-4D98-BD1F-E78CAFEFAE83 Q34424865-01D10A29-2AB0-4CEC-9320-D0F794916CE2 Q34426216-60EFDB10-6470-46FF-AC6C-EA09EAB2FDEF Q34459775-C76C68E0-09F1-459B-AB9F-6290FE4C3EFA Q34473840-98450D04-2660-481B-8B75-673B8A8570ED Q34555598-B82547AF-ED49-40D6-BF51-988F13CDAF5A Q34708116-682B536E-34EA-4853-A5DF-D68668EE9C3D Q34731202-E1605D6C-4BE6-48B2-B54F-4E64E931A7D5 Q34975631-640B5728-0CBE-4127-BB7D-D4FED54F8C32 Q35023117-987C6990-AA4C-431B-9BEB-C5F6FD49AF97 Q35026088-CE353C99-9ED3-473A-800E-4D4BDF161B4D Q35032056-C198C26F-9F6A-403E-8788-1A1BF9CC0C90 Q35074796-637B643B-899E-4D29-9907-97BA8E5B2ABA Q35117863-E5FFA485-1F53-40A4-9D47-2648B65A2826 Q35150183-842C54EE-9D0D-44D3-84A3-4A5AC26807AA Q35592683-5E9F9B1E-0CE4-4FD0-B4D9-AA41578857CB Q35653883-75F42784-F30D-451A-9B97-8B114D7B5EC2 Q35715254-EDD7DFEB-094F-4FE0-BDD0-F2D55089AA36 Q35755912-3F501446-69EE-4B50-B7C6-C45D821FFA9D Q35952370-1730097F-C7B5-4A30-A6EC-48B589600E81

P2860

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.

http://www.wikidata.org/entity/Q42655084

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.

@en

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.

@nl

type

label

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.

@en

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.

@nl

prefLabel

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.

@en

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.

@nl

P1433

Q42655084-E3ECDAA1-7461-414F-BB13-0E4178AA929A

P1476

Q42655084-C1EAE62B-47B2-4A7B-9342-BC91C0559D07

P2093

Q42655084-0706607D-AFDF-4BB1-B069-A4C499EF77F8

Q42655084-0CF05A37-CBC0-43CB-A390-9020C818589B

Q42655084-20966A12-A969-4144-A313-6561EA000A5E

Q42655084-2C77FF4A-1C03-4B2D-8E01-610A9F0EF5EB

Q42655084-380F2DE2-65C3-4941-A385-E71FFD15B02F

Q42655084-3BF3B3D8-C112-48C7-BA32-E1D054227E7C

Q42655084-500CE0A1-BCB4-4D25-B3A0-154C06783CDC

Q42655084-715DE1F7-DE2D-4522-900A-525E081926DE

Q42655084-8C64F58F-6817-40CA-83F1-CD866922C4F8

Q42655084-B198B5E2-038C-4AA8-8CA3-85101C31B19F

P304

Q42655084-4D81C5C0-7141-4DA8-B438-0611D5DF40C0

P31

Q42655084-C0C748CF-E3BB-4B95-B2E4-7139A58DF35F

P356

Q42655084-B78085E9-4021-451E-993E-B4AFA64E48ED

P407

Q42655084-28B3369D-FB70-40CB-86D2-F45A7E8F291D

P433

Q42655084-1BEEFA17-480F-4FC4-9326-B793C1BB413D

P478

Q42655084-9428D19B-03B5-4CEF-99F9-6D294E865D68

P50

Q42655084-0E94BEBE-E77C-43C5-BFD9-10C5CEB1DB26

Q42655084-21ED1102-0776-4CD1-8D15-CF148F34FB6C

Q42655084-3178B9CF-19FC-49D3-B9EE-EA1A9A49C393

Q42655084-4E0B3DA9-1CC0-467D-B891-26381A456A2C

Q42655084-4F301D15-6CE0-4C88-9772-A7D77EF96136

Q42655084-6E10C518-1D4F-4D54-83E3-112BBE1871F5

Q42655084-A2FE2AA9-DEC2-4B6D-9890-5AA23A4B70E9

Q42655084-CC953452-29E7-471D-86B3-88650852452F

Q42655084-D1F226D0-F28B-4140-9FC1-9D706F0841C6

Q42655084-E63C6D2D-4FC5-412D-8276-75DE4DE5F1EA

P577

Q42655084-ABE7159D-5FFB-41B0-A682-2DF99345428E

P5875

Q42655084-9DD04A6C-6260-4B49-AFD1-8D7A3CBD2038

P698

Q42655084-7EC50834-AD93-4A35-9EC9-D6839EF98C74

P356

APPI.AJP.2009.09070932

P1433

American Journal of Psychiatry

P1476

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.

@en

P2093

Amy W Butler

http://www.w3.org/2001/XMLSchema#string

Anna Placentino

http://www.w3.org/2001/XMLSchema#string

Anne Farmer

http://www.w3.org/2001/XMLSchema#string

Astrid Zobel

http://www.w3.org/2001/XMLSchema#string

Borut Jerman

http://www.w3.org/2001/XMLSchema#string

Daniel Souery

http://www.w3.org/2001/XMLSchema#string

Joanna Hauser

http://www.w3.org/2001/XMLSchema#string

Katrina Pirlo

http://www.w3.org/2001/XMLSchema#string

Mandy Y M Ng

http://www.w3.org/2001/XMLSchema#string

Nader Perroud

http://www.w3.org/2001/XMLSchema#string

P304

555-564

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1176/APPI.AJP.2009.09070932

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

167

http://www.w3.org/2001/XMLSchema#string

P50

Marcella Rietschel

Michael R. Barnes

Katherine J. Aitchison

Sarah Cohen-Woods

Erik Roj Larsen

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42833540

http://www.w3.org/2001/XMLSchema#string

P698

20360315

http://www.w3.org/2001/XMLSchema#string